Concurrent Coprimary KIT Exon 17 and BRAF Mutations in a Small Intestinal GI Stromal Tumor-A Case Report [0.03%]
小肠GIST并KIT exon17和BRAF双原发突变一例报告
Hashim Ishfaq,Misbah Younus Soomro,Bakhtawar Masood et al.
Hashim Ishfaq et al.
Purpose: Gastrointestinal stromal tumors (GISTs) are rare neoplasms driven by mutations in KIT, PDGFRA, or BRAF. Concomitant KIT/BRAF mutations are exceptionally rare and have historically been regarded as mutually exclus...
Correction: Fecal Immunochemical Testing for Colorectal Cancer Prevention in Two Public Hospitals [0.03%]
纠正：两个公立医院结直肠癌预防的粪便免疫化学检测
Changlin Gong,Maria Teresa Medina Rojas,Maria Gabriela Rubianes Guerrero et al.
Changlin Gong et al.
Published Erratum
Journal of gastrointestinal cancer. 2025 May 10;56(1):115. DOI:10.1007/s12029-025-01223-x 2025
Personalized Care for Pancreatic Cancer: Harnessing Patient-Derived Organoids [0.03%]
个性化胰腺癌护理：利用患者衍生器官类器官模型进行精准医疗
L Demyan,M J Weiss
L Demyan
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal cancers. Surgical resection combined with appropriate chemotherapy currently offers the best chance for long-term survival and potential cure. However, effective treatment is ...
The Significance of Screening Endoscopy at 2-Year Interval for Detecting Pharyngeal and Esophageal Cancer in the Japanese General Population [0.03%]
日本普通人群每两年一次的筛查内镜检查在咽喉癌和食管癌检测中的意义
Kazuhiro Kashiwagi,Toshifumi Yoshida,Satoshi Kinoshita et al.
Kazuhiro Kashiwagi et al.
Purpose: We previously identified examination time and 2-year interval as effective quality indicators for detecting upper gastrointestinal cancer during screening esophagogastroduodenoscopy (EGD). We evaluated the signif...
Neoadjuvant Pembrolizumab Enables Successful Downstaging and Resection of Borderline Resectable MSI-H/dMMR Pancreatic Ductal Adenocarcinoma: A Case Report and Literature Review [0.03%]
派姆单抗新辅助治疗使部分可切除的胰腺导管腺癌患者病情减期并成功手术切除：一例报告及文献回顾
Kevin Zhao,Vijayaragavan Muralidharan,Shaun Brown et al.
Kevin Zhao et al.
Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with a poor prognosis. While immunotherapy has shown limited efficacy in most PDAC cases due to an immunosuppressive tumour microenviro...
Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Subepithelial Lesions: A Systematic Review and Meta-Analysis [0.03%]
上消化道黏膜下病变固有层内隧道切除的系统评价和 meta 分析
Stavros Chrysovalantis Liapis,Ioannis Baloyiannis,Konstantinos Perivoliotis et al.
Stavros Chrysovalantis Liapis et al.
Aim: Submucosal tunneling endoscopic resection (STER) is an advanced endoscopic technique used for the minimally invasive removal of subepithelial lesions of the gastrointestinal (GI) tract. The aim of this study was to e...
The Efficacy and Safety of Nivolumab Combined with Nab-Paclitaxel or Oxaliplatin as a First-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer [0.03%]
纳武利尤单抗联合白蛋白结合型紫杉醇或奥沙利铂一线治疗晚期或转移性胃癌和胃食管连接部癌的疗效及安全性：一项随机、双盲、安慰剂对照的Ⅱ期临床研究
Juan Li,Shuman Li,Ying Zhang et al.
Juan Li et al.
Objective: This study aims to assess the therapeutic efficacy and safety of nivolumab combined with chemotherapy as a first-line treatment for advanced or metastatic gastric cancer, specifically comparing the outcomes of ...
Multidisciplinary Management of Anorectal Melanoma: a Retrospective Analysis of Surgical and Systemic Therapies from the National Cancer Database [0.03%]
美国国家癌症数据库肛门恶性黑色素瘤多学科治疗的回顾性分析：外科和系统性疗法
Richard Sassun,Annaclara Sileo,Jyi Cheng Ng et al.
Richard Sassun et al.
Purpose: Anorectal melanoma (ARM) represents a problematic scenario due to a 5-year overall survival (OS) rate below 20% and its increasing incidence. Due to its comparable OS, local surgery (LS) has replaced radical surg...
Can Chemotherapy Facilitate Less Morbid Surgery in Multicentric Intra-abdominal Inflammatory Myofibroblastic Tumor? [0.03%]
化疗能否使腹腔内多中心炎性肌纤维母细胞瘤的手术治疗更加微创？
Devesh S Ballal,Poonam Panjwani,Samreen S Qureshi et al.
Devesh S Ballal et al.
Background: Inflammatory myofibroblastic tumor is a rare benign neoplasm affecting young adults and children. Although often considered benign, its locally aggressive nature and tendency to recur make its management immen...
Pancreatic Acinar Cell Carcinoma: Demographics, Treatment, and Survival Outcomes, A Retrospective Population-Based Study [0.03%]
胰腺内分泌肿瘤的流行病学、治疗及生存结局：基于人口的回顾性研究
Abdul Qahar Khan Yasinzai,Asif Iqbal,Diego Olavarria-Bernal et al.
Abdul Qahar Khan Yasinzai et al.
Purpose: Pancreatic acinar cell carcinoma accounts for 1-2% of pancreatic tumors, with increasing frequency in recent years, and still represents a poor prognosis. This study aims to expand and update existing literature ...